XIAOLING QU: Open Payments
NPI 1457893455 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 9 payments from 7 companies in 2025. Trend: 2023 $31 · 2024 $40 · 2025 $183
Food & beverage: $161Education: $22
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $49 |
| Alexion Pharmaceuticals, Inc. | 2 | $34 |
| OPKO Pharmaceuticals, LLC | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: TARPEYO, ULTOMIRIS, RAYALDEE, ZENPEP, Kerendia, IBSRELA, JYNARQUE.
Industry payments across OH — which companies pay providers there.
